367 related articles for article (PubMed ID: 26712592)
21. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
García-Reyne A; Lumbreras C; Fernández I; Colina F; Abradelo M; Magan P; San-Juan R; Manrique A; López-Medrano F; Fuertes A; Lizasoain M; Moreno E; Aguado JM
Transpl Infect Dis; 2013 Aug; 15(4):405-15. PubMed ID: 23725370
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
[TBL] [Abstract][Full Text] [Related]
23. Pre- and Post-Transplant Treatment of Viral Hepatitis C.
Mutimer D
Dig Dis; 2017; 35(4):347-350. PubMed ID: 28468002
[TBL] [Abstract][Full Text] [Related]
24. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?
Visentini M; Fiorilli M; Casato M
Expert Rev Hematol; 2017 Aug; 10(8):719-727. PubMed ID: 28675071
[TBL] [Abstract][Full Text] [Related]
25. Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals Era.
Devresse A; Delire B; Lazarus JV; Kabamba B; De Meyer M; Mourad M; Buemi A; Darius T; Cambier JF; Goffin E; Jadoul M; Kanaan N
Transplant Proc; 2020 Apr; 52(3):815-822. PubMed ID: 32143864
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus and nonliver solid organ transplantation.
Carbone M; Mutimer D; Neuberger J
Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130
[TBL] [Abstract][Full Text] [Related]
27. [Application of direct antiviral drugs in special patients with HCV infection].
Jiang C; Liu CY; Shao S; Gao YH
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):316-320. PubMed ID: 29996347
[TBL] [Abstract][Full Text] [Related]
28. Direct-acting agents for hepatitis C virus before and after liver transplantation.
Sugawara Y; Hibi T
Biosci Trends; 2018 Jan; 11(6):606-611. PubMed ID: 29238003
[TBL] [Abstract][Full Text] [Related]
29. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
30. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
Lin M; Kramer J; White D; Cao Y; Tavakoli-Tabasi S; Madu S; Smith D; Asch SM; El-Serag HB; Kanwal F
Aliment Pharmacol Ther; 2017 Nov; 46(10):992-1000. PubMed ID: 28949020
[TBL] [Abstract][Full Text] [Related]
31. Entry inhibitors and future treatment of hepatitis C.
Fofana I; Jilg N; Chung RT; Baumert TF
Antiviral Res; 2014 Apr; 104():136-42. PubMed ID: 24525381
[TBL] [Abstract][Full Text] [Related]
32. Acute myeloid leukaemia following direct acting antiviral drugs in HCV-infected patients: A 10 years' retrospective single-center study.
Scheifer C; Luckina E; Lebrun-Vignes B; Diop AA; Damais-Thabut D; Roos-Weil D; Dechartres A; Lebray P
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):102000. PubMed ID: 35933093
[TBL] [Abstract][Full Text] [Related]
33. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
34. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
35. Management of Post-Liver Transplant Recurrence of Hepatitis C.
Taylor J; Cox-North P; Landis CS
Drugs; 2016 Dec; 76(18):1711-1717. PubMed ID: 27878476
[TBL] [Abstract][Full Text] [Related]
36. Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.
Torres HA; Mahale P
Liver Int; 2015 Jun; 35(6):1661-4. PubMed ID: 25779000
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic cell transplant in HCV-infected patients.
Peffault de Latour R; Ribaud P; Robin M; Valla D; Marcellin P; Socié G; Asselah T
J Hepatol; 2008 Jun; 48(6):1008-17. PubMed ID: 18433917
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplant.
Cunningham HE; Shea TC; Grgic T; Lachiewicz AM
Transpl Infect Dis; 2019 Jun; 21(3):e13091. PubMed ID: 30972834
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.
Ljungman P; Locasciulli A; de Soria VG; Békássy AN; Brinch L; Espigado I; Ferrant A; Franklin IM; O'Riordan J; Rovira M; Shaw P; Einsele H;
Bone Marrow Transplant; 2012 Sep; 47(9):1217-21. PubMed ID: 22158388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
